NCT00375778
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
- Locations
-
- PET center, Aarhus University Hospital Aarhus, Denmark
Clinical trial condition
Synucleinopathies
Explore clinical trials studying Synucleinopathies. Study availability and eligibility vary by location and protocol.
3,570 public trials
658 recruiting studies
Synucleinopathies trial results
NCT00029809
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
- Emory University School of Medicine Atlanta, Georgia, United States
NCT00029276
- Conditions
- Basal Ganglia Diseases, Behavior, Behavioral Symptoms, +10 more
- Locations
-
- Emory University Atlanta, Georgia, United States
Completed
Effect of Deep Brain Stimulation on Depression and Quality of Life in Parkinson's Patients
NCT00179101
- Conditions
- Basal Ganglia Diseases, Behavior, Behavioral Symptoms, +10 more
- Locations
-
- Vanderbilt University Nashville, Tennessee, United States
NCT00070928
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +13 more
- Locations
-
- Emory University Medical School/Wesley Woods Hospital Atlanta, Georgia, United States
NCT00001365
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +8 more
- Locations
-
- National Institute of Neurological Disorders and Stroke (NINDS) Bethesda, Maryland, United States
Completed
Study Evaluating Sumanirole for the Treatment of the Signs and Symptoms of Early Parkinson's Disease
NCT00058838
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
- Pfizer Investigational Site Birmingham, Alabama, United States
- Pfizer Investigational Site Birmingham, Alabama, United States
- Pfizer Investigational Site Huntsville, Alabama, United States
- Pfizer Investigational Site Little Rock, Arkansas, United States
NCT00036218
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
- Pfizer Investigational Site Hot Springs, Arkansas, United States
- Pfizer Investigational Site Little Rock, Arkansas, United States
- Pfizer Investigational Site Carmichael, California, United States
- Pfizer Investigational Site Fresno, California, United States
NCT00042692
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
- Locations
-
Not specified
Completed
Continued Efficacy and Safety of Apomorphine in Patients With Late-Stage Parkinsons Disease
NCT00200525
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
Not specified